Norgine Completes Acquisition of Theravia
August 14, 2025
Norgine completed its acquisition of Theravia, an international pharmaceutical company focused on therapies for patients with rare and debilitating conditions. Following closing, Theravia became a wholly owned subsidiary of Norgine, which will begin a structured integration process.
- Buyers
- Norgine
- Targets
- Theravia
- Sellers
- Mérieux Equity Partners
- Industry
- Pharmaceuticals
- Location
- France
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.